Treatment of insomnia with zaleplon

被引:0
|
作者
Dadasheva, M. I. [1 ]
机构
[1] Moscow Reg Inst Sci Res, Moscow, Russia
关键词
D O I
暂无
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
引用
收藏
页码:82 / 83
页数:2
相关论文
共 50 条
  • [21] Short-Term Efficacy of Zaleplon in Older Patients with Chronic Insomnia
    James K. Walsh
    June Fry
    Gary S. Richardson
    Martin B. Scharf
    Gerald W. Vogel
    Clinical Drug Investigation, 2000, 20 : 143 - 149
  • [22] Noise-induced sleep maintenance insomnia: hypnotic and residual effects of zaleplon
    Stone, BM
    Turner, C
    Mills, SL
    Paty, I
    Patat, A
    Darwish, M
    Danjou, P
    BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 2002, 53 (02) : 196 - 202
  • [23] A 6-Week Open-Label Study of Treatment of Insomnia With Zaleplon in HIV Positive Patients With Comorbid Depression
    Sharma, Anup
    Sengupta, Arjun
    Taylor, Lynne
    Morales, Knashawn H.
    Moore, Tyler M.
    Gur, Ruben C.
    Thase, Michael E.
    Weljie, Aalim
    Kayser, Matthew S.
    NEUROPSYCHOPHARMACOLOGY, 2017, 42 : S311 - S311
  • [24] Essential Oils Enriched Self-nano-emulsifying Systems for Effective Oral Delivery of Zaleplon for Improvement of Insomnia Treatment
    El-Enin, Hadel A. Abo
    Khalifa, Amany Salah
    INDIAN JOURNAL OF PHARMACEUTICAL EDUCATION AND RESEARCH, 2022, 56 (04) : 1031 - 1043
  • [25] ZALEPLON VERSUS ZOLPIDEM USE IN OLDER ADULTS BEING TREATED FOR INSOMNIA: A REVIEW
    Marbin, Aaron
    Brooke, Miles
    Thomas, Beatrice
    Martinez, Brian Macias
    Blum, Brian
    Neuhut, Samuel
    AMERICAN JOURNAL OF GERIATRIC PSYCHIATRY, 2023, 31 (03) : S68 - S69
  • [26] Unraveling the Power of Zaleplon Laden MCM-41 Silica Nano-carriers: In Vitro and In Vivo Assessment for Insomnia Treatment
    Pandya, Vidhi
    Trivedi, Nidhi
    Patel, Amit A.
    Prajapati, Bhupendra G.
    Patel, Samir G.
    Patel, Archita
    Solanki, Vanraj
    Patel, Alkesh
    Patel, Preyash
    Zinzuvadia, Diwayanshi
    Patel, Ravish J.
    BIONANOSCIENCE, 2024, 14 (03) : 2377 - 2390
  • [27] Efficacy and Tolerability of 14-Day Administration of Zaleplon 5mg and 10mg for the Treatment of Primary Insomnia
    James K. Walsh
    June Fry
    Charles W. Erwin
    Martin Scharf
    Thomas Roth
    Gerald W. Vogel
    Clinical Drug Investigation, 1998, 16 : 347 - 354
  • [28] Efficacy and tolerability of 14-day administration of zaleplon 5mg and 10mg for the treatment of primary insomnia
    Walsh, JK
    Fry, J
    Erwin, CW
    Scharf, M
    Roth, T
    Vogel, GW
    CLINICAL DRUG INVESTIGATION, 1998, 16 (05) : 347 - 354
  • [29] Zaleplon shortens subjective sleep latency and improves subjective sleep quality in elderly patients with insomnia
    Hedner, J
    Yaeche, R
    Emilien, G
    Farr, I
    Salinas, E
    INTERNATIONAL JOURNAL OF GERIATRIC PSYCHIATRY, 2000, 15 (08) : 704 - 712
  • [30] Zaleplon
    Hurst, M
    Noble, S
    CNS DRUGS, 1999, 11 (05) : 387 - 392